
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Companys allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa
Jcyte, inc operates in the Biotechnology industry.
Jcyte, inc's revenue is 11m - 100m
Jcyte, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.